DELRAY BEACH, Fla. A company that develops healthcare and information management products has applied for a patent for an insulin-pen tracking and recording device.

PositiveID announced Monday that it had filed for a patent for the Insulin Tracker with the U.S. Patent and Trademark Office. The device slides onto insulin pens and allows diabetes patients to track and record the amount of insulin they inject, including the time and date of each injection, transmitting it to PositiveID’s iGlucose System database and allowing patients and their healthcare providers to monitor compliance.

“Due to the cumbersome nature of manually recording blood glucose levels, insulin dosages and the appropriate dates and times for each, many patients’ diabetes logs are incomplete or even nonexistent, which directly impacts patient compliance,” PositiveID chairman and CEO Scott Silverman said.